Drug Repurposing: Considerations for Selection Criteria and Prioritization
Wed, Aug 05
|A hybrid meeting and requires registration
a hybrid public meeting hosted by the Regan-Udall Foundation in collaboration with the Food and Drug Administration (FDA).
Time & Location
Aug 05, 2026, 10:30 AM – 5:00 PM EDT
A hybrid meeting and requires registration
About the event
To register for the in-person or online meeting you must register at Drug Repurposing: Considerations for Selection Criteria and Prioritization. This meeting will include an overview of FDA's drug repurposing framework and a summary of comments submitted in response to the recent Request for Information. Speakers will include federal agency representatives, clinicians, researchers, and patient organizations. The goal is to hear a variety of perspectives; therefore, the meeting organizer will allocate in-person and virtual speaking slots across stakeholder groups. The public comment request deadline is Tuesday, July 21, 2026. Click here for more information.